NCT07092254View on ClinicalTrials.gov

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

760

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

April 8, 2026

Conditions
Triple Negative Breast Cancer
Interventions
DRUG

No drug

No study drug will be administered in this non-interventional study.

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY